Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Echocardiographic determination of pulmonary arterial capacitance.

Papolos A, Fan E, Wagle RR, Foster E, Boyle AJ, Yeghiazarians Y, MacGregor JS, Grossman W, Schiller NB, Ganz P, Tison GH.

Int J Cardiovasc Imaging. 2019 Sep;35(9):1581-1586. doi: 10.1007/s10554-019-01595-9. Epub 2019 Apr 9.

PMID:
30968263
2.

Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy.

Tietjens JR, Claman D, Kezirian EJ, De Marco T, Mirzayan A, Sadroonri B, Goldberg AN, Long C, Gerstenfeld EP, Yeghiazarians Y.

J Am Heart Assoc. 2019 Jan 8;8(1):e010440. doi: 10.1161/JAHA.118.010440. No abstract available.

3.

TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels.

Browne S, Jha AK, Ameri K, Marcus SG, Yeghiazarians Y, Healy KE.

PLoS One. 2018 Mar 22;13(3):e0194679. doi: 10.1371/journal.pone.0194679. eCollection 2018.

4.

Aging is protective against pressure overload cardiomyopathy via adaptive extracellular matrix remodeling.

Geng X, Hwang J, Ye J, Shih H, Coulter B, Naudin C, Jun K, Sievers R, Yeghiazarians Y, Lee RJ, Boyle AJ.

Am J Cardiovasc Dis. 2017 Jun 15;7(3):72-82. eCollection 2017.

5.

Three-Dimensional Bioprinting: Emerging Technology in Cardiovascular Medicine.

Ameri K, Samurkashian R, Yeghiazarians Y.

Circulation. 2017 Apr 4;135(14):1281-1283. doi: 10.1161/CIRCULATIONAHA.116.024945. No abstract available.

PMID:
28373522
6.

Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency.

Kallianos K, Henry TS, Yeghiazarians Y, Zimmet J, Shunk KA, Tseng EE, Mahadevan V, Hope MD.

Int J Cardiol. 2017 Mar 15;231:255-257. doi: 10.1016/j.ijcard.2016.12.147. Epub 2016 Dec 30.

7.

Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.

Jha AK, Tharp KM, Browne S, Ye J, Stahl A, Yeghiazarians Y, Healy KE.

Biomaterials. 2016 May;89:136-47. doi: 10.1016/j.biomaterials.2016.02.023. Epub 2016 Mar 3.

8.

Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.

Chen Q, Varga M, Wang X, Haddad DJ, An S, Medzikovic L, Derakhshandeh R, Kostyushev DS, Zhang Y, Clifford BT, Luu E, Danforth OM, Rafikov R, Gong W, Black SM, Suchkov SV, Fineman JR, Heiss C, Aschbacher K, Yeghiazarians Y, Springer ML.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002257. doi: 10.1161/JAHA.115.002257.

9.

Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mTc-tetrofosmin: Method and validation.

Shrestha U, Sciammarella M, Alhassen F, Yeghiazarians Y, Ellin J, Verdin E, Boyle A, Seo Y, Botvinick EH, Gullberg GT.

J Nucl Cardiol. 2017 Feb;24(1):268-277. doi: 10.1007/s12350-015-0320-3. Epub 2015 Dec 29.

10.

Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction.

Ye J, Gaur M, Zhang Y, Sievers RE, Woods BJ, Aurigui J, Bernstein HS, Yeghiazarians Y.

PLoS One. 2015 Jul 31;10(7):e0131123. doi: 10.1371/journal.pone.0131123. eCollection 2015.

11.

Cardiac stem cell therapy: Have we put too much hype in which cell type to use?

Ye J, Yeghiazarians Y.

Heart Fail Rev. 2015 Sep;20(5):613-9. doi: 10.1007/s10741-015-9494-7. Review.

PMID:
26024953
12.

A Novel Method for Quantifying Smooth Regional Variations in Myocardial Contractility Within an Infarcted Human Left Ventricle Based on Delay-Enhanced Magnetic Resonance Imaging.

Genet M, Chuan Lee L, Ge L, Acevedo-Bolton G, Jeung N, Martin A, Cambronero N, Boyle A, Yeghiazarians Y, Kozerke S, Guccione JM.

J Biomech Eng. 2015 Aug;137(8):081009. doi: 10.1115/1.4030667. Epub 2015 Jun 16.

13.

Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Jha AK, Mathur A, Svedlund FL, Ye J, Yeghiazarians Y, Healy KE.

J Control Release. 2015 Jul 10;209:308-16. doi: 10.1016/j.jconrel.2015.04.034. Epub 2015 Apr 27.

14.

HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth.

Ameri K, Jahangiri A, Rajah AM, Tormos KV, Nagarajan R, Pekmezci M, Nguyen V, Wheeler ML, Murphy MP, Sanders TA, Jeffrey SS, Yeghiazarians Y, Rinaudo PF, Costello JF, Aghi MK, Maltepe E.

Cell Rep. 2015 Feb 17;10(6):891-899. doi: 10.1016/j.celrep.2015.01.020. Epub 2015 Feb 13.

15.

Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels.

Jha AK, Tharp KM, Ye J, Santiago-Ortiz JL, Jackson WM, Stahl A, Schaffer DV, Yeghiazarians Y, Healy KE.

Biomaterials. 2015 Apr;47:1-12. doi: 10.1016/j.biomaterials.2014.12.043. Epub 2015 Jan 22.

16.

Cardiac steatosis potentiates angiotensin II effects in the heart.

Glenn DJ, Cardema MC, Ni W, Zhang Y, Yeghiazarians Y, Grapov D, Fiehn O, Gardner DG.

Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H339-50. doi: 10.1152/ajpheart.00742.2014. Epub 2014 Dec 5.

17.

Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.

Feng K, Gupta V, Terrazas E, Yeghiazarians Y, Ports T, Gregoratos G, Tavakol M, Roberts JP, Boyle A.

Am J Cardiovasc Dis. 2014 Oct 11;4(3):133-9. eCollection 2014.

18.

Quantitative Signature of Coronary Steal in a Patient with Occluded Coronary Arteries Supported by Collateral Circulation Using Dynamic SPECT.

Shrestha U, Botvinick EH, Yeghiazarians Y, Seo Y, Gullberg GT.

IEEE Nucl Sci Symp Conf Rec (1997). 2014 Nov;2014. doi: 10.1109/NSSMIC.2014.7430923.

19.

High femoral artery bifurcation predicts contralateral high bifurcation: implications for complex percutaneous cardiovascular procedures requiring large caliber and/or dual access.

Gupta V, Feng K, Cheruvu P, Boyer N, Yeghiazarians Y, Ports TA, Zimmet J, Shunk K, Boyle AJ.

J Invasive Cardiol. 2014 Sep;26(9):409-12.

20.

Patient and physician perspectives on outcomes weighting in revascularization. The POWR study.

Pandit J, Gupta V, Boyer N, Yeghiazarians Y, Ports TA, Boyle AJ.

Int J Cardiol. 2014 Dec 15;177(2):513-4. doi: 10.1016/j.ijcard.2014.08.096. Epub 2014 Aug 23. No abstract available.

PMID:
25194864
21.

Coronary artery aneurysms in acute coronary syndrome: case series, review, and proposed management strategy.

Boyer N, Gupta R, Schevchuck A, Hindnavis V, Maliske S, Sheldon M, Drachman D, Yeghiazarians Y.

J Invasive Cardiol. 2014 Jun;26(6):283-90. Review.

22.

IL-15: a novel prosurvival signaling pathway in cardiomyocytes.

Yeghiazarians Y, Honbo N, Imhof I, Woods B, Aguilera V, Ye J, Boyle AJ, Karliner JS.

J Cardiovasc Pharmacol. 2014 May;63(5):406-11. doi: 10.1097/FJC.0000000000000061.

23.

Dietary flavanol intervention lowers the levels of endothelial microparticles in coronary artery disease patients.

Horn P, Amabile N, Angeli FS, Sansone R, Stegemann B, Kelm M, Springer ML, Yeghiazarians Y, Schroeter H, Heiss C.

Br J Nutr. 2014 Apr 14;111(7):1245-52. doi: 10.1017/S0007114513003693. Epub 2013 Nov 29.

24.

The effects of aging on apoptosis following myocardial infarction.

Boyle AJ, Hwang J, Ye J, Shih H, Jun K, Zhang Y, Fang Q, Sievers R, Yeghiazarians Y, Lee RJ.

Cardiovasc Ther. 2013 Dec;31(6):e102-10. doi: 10.1111/1755-5922.12043.

25.

The effects of intra-arterial vasodilators on radial artery size and spasm: implications for contemporary use of trans-radial access for coronary angiography and percutaneous coronary intervention.

Boyer N, Beyer A, Gupta V, Dehghani H, Hindnavis V, Shunk K, Zimmet J, Yeghiazarians Y, Ports T, Boyle A.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):321-4. doi: 10.1016/j.carrev.2013.08.009. Epub 2013 Oct 2.

PMID:
24095616
26.

Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction.

Ye J, Yeghiazarians Y.

J Cardiovasc Pharmacol. 2014 Feb;63(2):85-94. doi: 10.1097/FJC.0b013e318299ebc0. Review.

PMID:
23674056
27.

Nuclear localization of the mitochondrial factor HIGD1A during metabolic stress.

Ameri K, Rajah AM, Nguyen V, Sanders TA, Jahangiri A, Delay M, Donne M, Choi HJ, Tormos KV, Yeghiazarians Y, Jeffrey SS, Rinaudo PF, Rowitch DH, Aghi M, Maltepe E.

PLoS One. 2013 Apr 30;8(4):e62758. doi: 10.1371/journal.pone.0062758. Print 2013.

28.

Topical nitroglycerin and lidocaine to dilate the radial artery prior to transradial cardiac catheterization: a randomized, placebo-controlled, double-blind clinical trial: the PRE-DILATE Study.

Beyer AT, Ng R, Singh A, Zimmet J, Shunk K, Yeghiazarians Y, Ports TA, Boyle AJ.

Int J Cardiol. 2013 Oct 3;168(3):2575-8. doi: 10.1016/j.ijcard.2013.03.048. Epub 2013 Apr 10.

PMID:
23582415
29.

Aging Impairs the Proliferative Capacity of Cardiospheres, Cardiac Progenitor Cells and Cardiac Fibroblasts: Implications for Cell Therapy.

Ye J, Hom DS, Hwang J, Yeghiazarians Y, Lee RJ, Boyle AJ.

J Clin Med. 2013 Sep 23;2(3):103-14. doi: 10.3390/jcm2030103.

30.

Cellular microparticles in the pathogenesis of pulmonary hypertension.

Amabile N, Guignabert C, Montani D, Yeghiazarians Y, Boulanger CM, Humbert M.

Eur Respir J. 2013 Jul;42(1):272-9. doi: 10.1183/09031936.00087212. Epub 2012 Dec 20. Review.

31.

CD45-positive cells are not an essential component in cardiosphere formation.

Ye J, Boyle AJ, Shih H, Sievers RE, Wang ZE, Gormley M, Yeghiazarians Y.

Cell Tissue Res. 2013 Jan;351(1):201-5. doi: 10.1007/s00441-012-1511-8. Epub 2012 Oct 13.

PMID:
23064904
32.

Topical nitroglycerin and lidocaine locally vasodilate the radial artery without affecting systemic blood pressure: a dose-finding phase I study.

Majure DT, Hallaux M, Yeghiazarians Y, Boyle AJ.

J Crit Care. 2012 Oct;27(5):532.e9-13. doi: 10.1016/j.jcrc.2012.04.019. Epub 2012 Jun 12.

PMID:
22699036
33.

Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease.

Wang X, Takagawa J, Haddad DJ, Pinnamaneni K, Zhang Y, Sievers RE, Grossman W, Yeghiazarians Y, Springer ML.

J Tissue Sci Eng. 2011 Nov 18;S3. pii: 002.

34.

Injection of human bone marrow and mononuclear cell extract into infarcted mouse hearts results in functional improvement.

Angeli FS, Zhang Y, Sievers R, Jun K, Yim S, Boyle A, Yeghiazarians Y.

Open Cardiovasc Med J. 2012;6:38-43. doi: 10.2174/1874192401206010038. Epub 2012 Apr 17.

35.

Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction.

Koskenvuo JW, Sievers RE, Zhang Y, Angeli FS, Lee B, Shih H, Ye J, Boyle AJ, Yeghiazarians Y.

Ann Med. 2012 Dec;44(8):829-35. doi: 10.3109/07853890.2012.672026. Epub 2012 Apr 12.

PMID:
22494088
36.

Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury.

Ye J, Boyle A, Shih H, Sievers RE, Zhang Y, Prasad M, Su H, Zhou Y, Grossman W, Bernstein HS, Yeghiazarians Y.

PLoS One. 2012;7(1):e30329. doi: 10.1371/journal.pone.0030329. Epub 2012 Jan 17.

37.

Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals.

Aschbacher K, Chen Q, Varga M, Haddad DJ, Yeghiazarians Y, Epel E, Wolkowitz OM, Springer ML.

Am J Cardiovasc Dis. 2012;2(1):12-9. Epub 2011 Oct 3.

38.

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Yeghiazarians Y, Gaur M, Zhang Y, Sievers RE, Ritner C, Prasad M, Boyle A, Bernstein HS.

Cytotherapy. 2012 Feb;14(2):223-31. doi: 10.3109/14653249.2011.623690. Epub 2011 Oct 31.

39.

Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group?

Koskenvuo JW, Mirsky R, Zhang Y, Helenius H, Angeli FS, De Marco T, Boyle AJ, Yeghiazarians Y.

Clin Physiol Funct Imaging. 2011 Nov;31(6):477-84. doi: 10.1111/j.1475-097X.2011.01049.x. Epub 2011 Sep 2.

PMID:
21981460
40.

Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, Zhang Y, Yeghiazarians Y, Gardner DG.

Circulation. 2011 Oct 25;124(17):1838-47. doi: 10.1161/CIRCULATIONAHA.111.032680. Epub 2011 Sep 26.

41.

Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M, Springer ML.

Sci Transl Med. 2011 Sep 14;3(100):100ra90. doi: 10.1126/scitranslmed.3002814.

42.

Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man.

Boyle AJ, Yeghiazarians Y, Shih H, Hwang J, Ye J, Sievers R, Zheng D, Palasubramaniam J, Palasubramaniam D, Karschimkus C, Whitbourn R, Jenkins A, Wilson AM.

J Transl Med. 2011 Sep 12;9:150. doi: 10.1186/1479-5876-9-150.

43.

Post myocardial infarction cardiogenic shock: a review of current therapies.

Ng R, Yeghiazarians Y.

J Intensive Care Med. 2013 May-Jun;28(3):151-65. doi: 10.1177/0885066611411407. Epub 2011 Jul 11. Review.

PMID:
21747126
44.

Atherosclerotic renal artery stenosis--diagnosis and treatment.

Lao D, Parasher PS, Cho KC, Yeghiazarians Y.

Mayo Clin Proc. 2011 Jul;86(7):649-57. doi: 10.4065/mcp.2011.0181. Review.

45.

Sterile radial artery granuloma after transradial cardiac catheterization.

Zellner C, Yeghiazarians Y, Ports TA, Ursell P, Boyle AJ.

Cardiovasc Revasc Med. 2011 May-Jun;12(3):187-189. doi: 10.1016/j.carrev.2010.06.003. Epub 2010 Oct 20.

PMID:
21640939
46.

Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography.

Hoffmayer KS, Zellner C, Kwan DM, Konety S, Foster E, Moore P, Yeghiazarians Y.

Tex Heart Inst J. 2011;38(1):81-4.

47.

Treatment of pulmonary arterial hypertension with circulating angiogenic cells.

Mirsky R, Jahn S, Koskenvuo JW, Sievers RE, Yim SM, Ritner C, Bernstein HS, Angeli FS, Boyle AJ, De Marco T, Yeghiazarians Y.

Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L12-9. doi: 10.1152/ajplung.00215.2010. Epub 2011 Mar 11.

48.

Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.

Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R.

Exp Gerontol. 2011 Jul;46(7):549-59. doi: 10.1016/j.exger.2011.02.010. Epub 2011 Mar 3.

49.

A murine model of isolated cardiac steatosis leads to cardiomyopathy.

Glenn DJ, Wang F, Nishimoto M, Cruz MC, Uchida Y, Holleran WM, Zhang Y, Yeghiazarians Y, Gardner DG.

Hypertension. 2011 Feb;57(2):216-22. doi: 10.1161/HYPERTENSIONAHA.110.160655. Epub 2011 Jan 10.

50.

Subclavian artery stenosis: a review for the vascular medicine practitioner.

Ochoa VM, Yeghiazarians Y.

Vasc Med. 2011 Feb;16(1):29-34. doi: 10.1177/1358863X10384174. Epub 2010 Nov 15. Review.

PMID:
21078767

Supplemental Content

Loading ...
Support Center